ArticleDigestive diseases and sciences2026

Higher Off-Therapy Relapse Risk with Tenofovir Alafenamide than Entecavir in Non-cirrhotic HBeAg-Negative Chronic Hepatitis B: Insights from End-of-Treatment qHBsAg Stratification.

Yi-Jie Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.